Prostaglandins and cholinomimetics

Archives of Ophthalmology

Volumn 115, Issue 7, 1997, Pages 911-913

  Kaufman, Paul L ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LATANOPROST; PROSTAGLANDIN F2 ALPHA;

ANTIHYPERTENSIVE ACTIVITY; AQUEOUS HUMOR FORMATION; AQUEOUS HUMOR OUTFLOW; DRUG EFFECT; EDITORIAL; HUMAN; INTRAOCULAR HYPERTENSION; PRIORITY JOURNAL;

EID: 0030877611     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.1997.01100160081013     Document Type: Editorial

References (41)

1. Camras CB. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month, masked, multicenter trial in the United States. Ophthalmology. 1996;103:138-147.
2. 2α-1-isopropylester applied in multiple doses in ocular hypertensive and glaucoma patients. Ophthalmology. 1989;96:1329-1337.
3. Alm A. Comparative phase III clinical trial of latanoprost and timolol in patients with elevated intraocular pressure. Adv Prostaglandin Thromboxane Leukot Res. 1995;23:527-532.
4. Alm A, Widengard I, Kjeligren D, et al. Latanoprost administered once daily caused a maintained reduction of intraocular pressure in glaucoma patients treated concomitantly with timolol. Br J Ophthalmol. 1995;79:12-16.
5. Watson P, Stjernschantz J. A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension: The Latanoprost Study Group. Ophthalmology. 1996;103:126-137.
6. Mishima HK, Masuda, Kitazawa Y, Azuma I, Araie M. A comparison of latanoprost and timolol in primary open-angle glaucoma and ocular hypertension: a 12-week study. Arch Ophthalmol. 1996;114:929-932.
7. 2α isopropylester on intraocular pressure, refraction and pupil diameter in monkeys. Invest Ophthalmol Vis Sci. 1991;32:510-519.
8. 2α-1 isopropylester in the cynomolgus monkey. Exp Eye Res. 1989;48:707-716.
9. 2α increases uveoscleral outflow in the cynomolgus monkey. Exp Eye Res. 1989;49:389-402.
10. van Alphen GWHM, Robinette SL, Macri FJ. Drug effects on ciliary muscle and choroid preparations in vitro. Arch Ophthalmol. 1962;68:111-123.
11. 2α effects on isolated rhesus monkey ciliary muscle. Invest Ophthalmol Vis Sci. 1995;36:2461-2465.
12. van Alphen GWHM, Wilhelm PB, Elsenfeld PW. The effect of prostaglandins on the isolated internal muscles of the mammalian eye, including man. Doc Ophthalmol. 1977;42:397-415.
13. 2α. Exp Eye Res. 1988;47:761-769.
14. 2α Fortschr Ophthalmol. 1990;87:623-629.
15. Kashiwagi K, Lindsey JD, Kashiwagi F, Weinreb RN. Extracellular matrix changes induced by prostaglandins in cultured human ciliary muscle cells. Invest Ophthalmol Vis Sci. 1995;36(suppl):S729. Abstract.
16. Lindsey JD, Kashiwagi K, Boyle D, Kashiwagi F, Firestein GS, Weinreb RN. Prostaglandins increase proMMP-1 and proMMP-3 secretion by human ciliary smooth muscle cells. Curr Eye Res. 1996;15:869-875.
17. Kaufman PL, Mittag TW. Medical therapy of glaucoma. In: Kaufman PL, Mittag TW, eds. Glaucoma. London, England: Mosby-Year Book Europe Ltd; 1994:9.7- 9.30.
18. Weinreb RN, Mitchell MD, Alvarado JA, Polansky JR. Glucocorticoid regulation of eicosanoid biosynthesis in cultured human trabecular cells. In: Ticho RDU, ed. Recent Advances in Glaucoma. Amsterdam, the Netherlands: Elsevier Science Publishers; 1984:213-218.
19. Matsumoto S, Yorio T, Magnino PE, DeSantis L, Pang IH. Endothelin-induced changes of second messengers in cultured human ciliary muscle cells. Invest Ophthalmol Vis Sci. 1996;37:1058-1066.
20. McGetrick JJ, Wilson DG, Dortzbach RK, Kaufman PL, Lemke BN. A search for lymphatic drainage of the monkey orbit. Arch Ophthalmol. 1989;107:255-260.
21. Toris CB, Pederson JE. Aqueous humor dynamics in experimental iridocyclitis. Invest Ophthalmol Vis Sci. 1987;28:477-481.
22. Bill A. Blood circulation and fluid dynamics in the eye. Physiol Rev. 1975;55:383-417.
23. Kaufman PL, Crawford K, Gabelt BT. The effects of prostaglandins on aqueous humor dynamics. In: Kooner KS, Zimmerman TJ, eds. New Ophthalmic Drugs. Philadelphia, Pa: WB Saunders Co: 1989:141-150.
24. Mäepea O, Bill A. The pressures in the episcleral veins, Schlemm's canal and the trabecular meshwork in monkeys: effects of changes in intraocular pressure. Exp Eye Res. 1989;49:645-663.
25. 2α on aqueous humor dynamics of rabbit, cat, and monkey. Invest Ophthalmol Vis Sci. 1984;25:1087- 1093.
26. Alm A, Villumsen J. PhXA34, a new potent ocular hypotensive drug: a study on dose-response relationship and on aqueous humor dynamics in healthy volunteers. Arch Ophthalmol. 1991;109:1564-1568.
27. 2α on trabecular outflow facility in cynomolgus monkeys. Exp Eye Res. 1990;51:87-91.
28. Bill A. Conventional and uveoscleral drainage of aqueous humor in the cynomolgus monkey (Macaca irus) at normal and high intraocular pressures. Exp Eye Res. 1966;5:45-54.
29. Bill A. Effects of longstanding stepwise increments in eye pressure on the rate of aqueous humor formation in a primate (Cercopithecus ethiops). Exp Eye Res. 1971;12:184-193.
30. 2α on aqueous humor dynamics in cynomolgus monkeys. Curr Eye Res. 1987;6:1035-1044.
31. Weinreb RN, Polansky JR, Alvarado JA, Mitchell MD. Arachidonic acid metabo- lism in human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 1988;29:1708-1712.
32. 2 on outflow facility in the human eye. Invest Ophthalmol Vis Sci. 1994;35:2053. Abstract.
33. 2α-1- isopropylester lowers Intraocular pressure without decreasing aqueous flow. Am J Ophthalmol. 1988;105:30-34.
34. 2α lowers intraocular pressure. In: Bito LZ, Stjernschantz J, eds. The Ocular Effects of Prostaglandins and Other Eicosanoids. New York, NY: Alan R Liss: 1989:387-416.
35. Hayashi M, Yablonski ME, Bito LZ. Eicosanoids as a new class of ocular hypotensive agents, II: comparison of the apparent mechanism of the ocular hypotensive effects of A and F type prostaglandins. Invest Ophthalmol Vis Sci. 1987;28:1639-1643.
36. Lindén C, Alm A. Latanoprost and physostigmine have mostly additive ocular hypotensive effects in human eyes. Arch Ophthalmol. 1997;115:857-861.
37. 2α. Arch Ophthalmol. 1987;105:1112-1116.
38. 2α/pilocarpine interactions on IOP and accommodation in monkeys. Exp Eye Res. 1995;61:677-683.
39. 2α on IOP in glaucomatous monkey eyes. Invest Ophthalmol Vis Sci. 1990;31:150. Abstract.
40. Bill A, Walinder P-E. The effects of pilocarpine on the dynamics of aqueous humor in a primate (Macaca irus). Invest Ophthalmol. 1966;5:170-175.
41. Kaufman PL, Bárány EH. Loss of acute pilocarpine effect on outflow facility following surgical disinsertion and retrodisplacement of the ciliary muscle from the scleral spur in the cynomolgus monkey. Invest Ophthalmol. 1976;15:793-807.